Journals / Türk Kardiyoloji Derneği Arşivi / 2015 / Cilt: 43 - Sayı: 6

Erken dönem gebelikte protez kapak trombozuna yönelik sıradışı trombolitik tedavi kararı

An unusual thrombolytic therapy decision in prosthetic valve thrombosis during early pregnancy

Pages
554–557
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case re- port describes a pregnant patient, whose echocardiogram showed evident gradient increase on her mechanical pros- thetic mitral valve, and who was treated successfully with tis- sue plasminogen activator for mechanical valve thrombosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Summary Pregnancy is among the risk factors for mechan- ical valve thrombosis, and even though thrombolytic therapy is contraindicated during pregnancy, it may be used in the treatment of this life-threatening complication.
📊
Key Findings & Data:Summary Pregnancy is among the risk factors for mechan- ical valve thrombosis, and even though thrombolytic therapy is contraindicated during pregnancy, it may be used in the treatment of this life-threatening complication.
💡
Conclusion & Impact:This case re- port describes a pregnant patient, whose echocardiogram showed evident gradient increase on her mechanical pros- thetic mitral valve, and who was treated successfully with tis- sue plasminogen activator for mechanical valve thrombosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Summary Pregnancy is among the risk factors for mechan- ical valve thrombosis, and even though thrombolytic therapy is contraindicated during pregnancy, it may be used in the treatment of this life-threatening complication. This case re- port describes a pregnant patient, whose echocardiogram showed evident gradient increase on her mechanical pros- thetic mitral valve, and who was treated successfully with tis- sue plasminogen activator for mechanical valve thrombosis.

Özet

Özet Mekanik kapak trombozu hayatı tehdit eden bir komplikasyon olup, gebelik de bu durum için bir risk faktörü olmaktadır. Trombolitik tedavi gebelik döneminde kontrendi- ke kabul edilse de, hayatı tehdit eden bu durumda kullanıla- bilmektedir. Bu yazıda, ekokardiyografi incelemesinde pro- tez kapağında tromboza bağlı yüksek basınç farkı ölçülen ve daha sonra trombolitik tedaviyle başarılı şekilde tedavi edilen bir gebe sunuldu.

🔖

Cite This Article

KÖKLÜ, E., ERKAL, Z., ARSLAN, Ş., KÜÇÜKSEYMEN, S., YÜKSEL, İ. Ö. (2022). Erken dönem gebelikte protez kapak trombozuna yönelik sıradışı trombolitik tedavi kararı. Türk Kardiyoloji Derneği Arşivi, Cilt: 43 - Sayı: 6, 554–557. https://ajindex.com/articles/632737

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107–15
  2. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191–6
  3. Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 2007;93:137–42
  4. Lengyel M, Vandor L. The role of thrombolysis in the man- agement of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis 2001;10:636–49
  5. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filip- patos G, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230–68
  6. Lengyel M, Horstkotte D, Völler H, Mistiaen WP; Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005;14:567–75
  7. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart As- sociation Task Force on Practice Guidelines. J Thorac Cardio- vasc Surg 2014;148:1–32
  8. Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. Massive pulmonary embolism during pregnancy successfully treat- ed with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med 2002;162:1221–7
  9. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, et al. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low- dose, slow infusion of tissue-type plasminogen activator. Cir- culation 2013;128:532–40
  10. Ozkan M, Kaymaz C, Kirma C, Sönmez K, Ozdemir N, Balkanay M, et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using se- rial transesophageal echocardiography. J Am Coll Cardiol 2000;35:1881–9.